SCHEMBL2118069

SCHEMBL2118069

[CH2]C(C)CC=CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2118064 1.00
SCHEMBL8960984 0.78 GRIK1 (0.31)
SCHEMBL8960989 0.78 GRIK1 (0.31)
SCHEMBL5881309 0.78 GRIK1 (0.32)
SCHEMBL8960700 0.77
SCHEMBL8960694 0.77
SCHEMBL8960619 0.76
SCHEMBL8960622 0.76
SCHEMBL5985953 0.75
SCHEMBL5985957 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114126606-B Method for dispersing a biofilm comprising gram-negative bacteria Q生物股份有限公司 2024-06-21 CN disclosed
US-20230250218-A1 URETHANE COMPOSITION NITTO KASEI CO., LTD. (JP) 2023-08-10 US disclosed
EP-4198068-A1 URETHANE COMPOSITION Nitto Kasei Co., Ltd. (JP) 2023-06-21 EP disclosed
CN-116018365-A Carbamate composition 日东化成株式会社 2023-04-25 CN disclosed
US-20230082311-A1 DRUG FOR CURATIVE THERAPY OF INTRACTABLE HEREDITARY RENAL ALPORT SYNDROME NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) 2023-03-16 US disclosed
CN-113603883-B Modified polyphenyl ether, preparation method and application in high-frequency circuit board 珠海宏昌电子材料有限公司 2023-01-10 CN disclosed
EP-4029514-A1 DRUG FOR CURATIVE THERAPY OF INTRACTABLE HEREDITARY RENAL ALPORT SYNDROME National University Corporation Kumamoto University (JP) 2022-07-20 EP disclosed
CN-114761033-A Medicament for radical therapy of refractory hereditary nephrotic Alport syndrome 国立大学法人熊本大学 2022-07-15 CN disclosed
EP-3986394-A1 BIOFILM DISRUPTION QBiotics Pty Ltd (AU) 2022-04-27 EP disclosed
CN-114126606-A Photocurable composition with variable viscosity Q生物股份有限公司 2022-03-01 CN disclosed
EP-0330025-A2 Antidiabetic composition comprising isocarbacyclin derivative TEIJIN LIMITED (JP) 1989-08-30 EP disclosed
US-4847259-A Nitrogen-containing heterocyclic compounds, and use as insecticide SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-07-11 US disclosed
US-4837342-A STABILITY SAGAMI CHEMICAL RESEARCH CENTER (JP) 1989-06-06 US disclosed
EP-0173754-B1 7-THIAPROSTAGLANDIN E 1?'S AND PROCESS FOR THEIR PREPARATION TEIJIN LIMITED (JP) 1989-04-26 EP disclosed
US-4755598-A 1'-(substituted)ethyl-7β-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylate derivatives having antibacterial utility TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1988-07-05 US disclosed
US-4714706-A JUVENILE HORMONE INHIBITORS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-12-22 US disclosed
EP-0234576-A1 Prostacyclin analogue, and blood circulation improving agent and anti-ulcer composition containing it as active ingredient SAGAMI CHEMICAL RESEARCH CENTER (JP) 1987-09-02 EP disclosed
EP-0203798-A2 Nitrogen-containing heterocyclic compounds, and their production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-12-03 EP disclosed
EP-0173754-A1 7-THIAPROSTAGLANDIN E 1?'S AND PROCESS FOR THEIR PREPARATION TEIJIN LIMITED (JP) 1986-03-12 EP disclosed
EP-0128028-A2 Cephalosporin derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1984-12-12 EP disclosed